Influenza News and Research

Latest Influenza News and Research

Study shows SARS-CoV-2 uses a receptor to efficiently infect human cells

To efficiently infect human cells, SARS-CoV-2, the virus that causes COVID-19, is able to use a receptor called Neuropilin-1, which is very abundant in many human tissues including the respiratory tract, blood vessels and neurons.

21 Oct 2020

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Now, a new study presented on the preprint server bioRxiv in October 2020 describes the efficient design of an mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), based on the use of the viral receptor-binding domain (RBD) mRNA encapsulated in lipid nanoparticles (LNP).

19 Oct 2020

Antigenic imprinting of sarbecovirus

A recent study published on the preprint server bioRxiv* in October 2020 shows that the design of a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) must consider the prior history of exposure to coronaviruses since these affect the antibody response to the virus.

19 Oct 2020

Untreated obstructive sleep apnea linked with increased hospitalization from flu

As we approach flu season, adults with obstructive sleep apnea may want to take extra precautions. A study published online as an accepted paper in the Journal of Clinical Sleep Medicine is the first to find that patients with sleep apnea who did not use CPAP therapy were more likely to be hospitalized with the flu.

19 Oct 2020

Study of patterns of social contacts early on in COVID-19 pandemic

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has compelled people worldwide to quarantine. To mitigate the transmission of SARS-CoV-2, countries and workplaces have been under varying stages of lockdown since the detection of the infection in December 2019 in Wuhan, China.

19 Oct 2020

New diagnostic test detects and identifies SARS-CoV-2 virus in less than five minutes

Scientists from Oxford University’s Department of Physics have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.

16 Oct 2020

New article explores the endemic potential of COVID-19 virus

A new article by Columbia Mailman School researchers Jeffrey Shaman and Marta Galanti explores the potential for the COVID-19 virus to become endemic, a regular feature producing recurring outbreaks in humans.

16 Oct 2020

Novel method can predict influenza epidemics

Researchers at Linköping University, Sweden, have developed a unique method to predict influenza epidemics by combining several sources of data.

16 Oct 2020

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, and the importance of flu vaccination during the 2020-2021 season.

16 Oct 2020

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

As scientists scramble to find effective vaccines and antivirals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent study published on the preprint server bioRxiv in October 2020 reports that the use of convalescent plasma to treat COVID-19 disease early in the course of the illness may be among the best available strategies at present.

16 Oct 2020

Researchers identify potential drugs that could be repurposed as pan-coronavirus treatments

A large international consortium of almost 200 researchers from 14 leading institutions in six countries has studied three different coronaviruses - SARS-CoV-1, SARS-CoV-2, and MERS-CoV - with the aim of finding vulnerabilities shared by these three pathogens.

15 Oct 2020

Cloud-based tool can rapidly detect and track emerging pathogens

Published today in the journal GigaScience is a new open source, cloud-based tool called IDseq that makes it possible to rapidly detect, identify, and track emerging pathogens such as SARS-CoV-2.

15 Oct 2020

SARS-CoV-2 may become endemic if reinfection proves commonplace, say researchers

To date, a few verified repeat SARS-CoV-2 infections have been documented around the world. "Should reinfection [with SARS-CoV-2] prove commonplace, and barring a highly effective vaccine delivered to most of the world's population, SARS-CoV-2 will likely become endemic," write Jeffrey Shaman and Marta Galanti in this Perspective.

15 Oct 2020

Research identifies antigen-specific peripheral T follicular helper cells in COVID-19 infected patients

Researchers have found peripheral T follicular helper cell responses to different structural proteins of SARS-CoV-2 and have studied how the response occurs over time.

14 Oct 2020

Combining genetic and experimental data can enable more accurate prediction of influenza virus

Combining genetic and experimental data into models about the influenza virus can help predict more accurately which strains will be most common during the next winter, says a study published recently in eLife.

14 Oct 2020

Understanding COVID-19 immunity is crucial for developing vaccination strategies

People who have recovered from COVID-19, and their close contacts, could hold the key to understanding how immunity to the disease develops, how long it lasts and what happens when immunity is lost.

14 Oct 2020

"Pandemic politics" is causing assaults on science and the public health

COVID-19 is now the third leading cause of death in the United States only behind cardiovascular disease and cancer.

14 Oct 2020

A "five-day switch" plan for schools reopenings during COVID-19

Researchers worked on mathematical predictions that could predict the safety of reopening schools in the U.S. Their study titled, “Safely Reopening K-12 Schools During the COVID-19 Pandemic,” is published preprint at the website medRxiv.

14 Oct 2020

Researchers create multi-functional nano-vaccine to prevent toxoplasmosis

Fighting clever parasites requires smart vaccines that can trigger critical immune responses. A University of Chicago-based research team has found a novel way to do that.

14 Oct 2020

AncestryDNA modeling study of 500,000 Americans sheds light on COVID-19 risk factors

Now, a new study by researchers at AncestryDNA, a company that provides DNA testing services that use modern autosomal testing technology, shows that some people are more susceptible to COVID-19 infection, and they may experience more severe outcomes, including males, the elderly, and those with comorbidities.

14 Oct 2020

Influenza News and Research

Latest Influenza News and Research

Study shows SARS-CoV-2 uses a receptor to efficiently infect human cells

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Antigenic imprinting of sarbecovirus

Untreated obstructive sleep apnea linked with increased hospitalization from flu

Study of patterns of social contacts early on in COVID-19 pandemic

New diagnostic test detects and identifies SARS-CoV-2 virus in less than five minutes

New article explores the endemic potential of COVID-19 virus

Novel method can predict influenza epidemics

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

Researchers identify potential drugs that could be repurposed as pan-coronavirus treatments

Cloud-based tool can rapidly detect and track emerging pathogens

SARS-CoV-2 may become endemic if reinfection proves commonplace, say researchers

Research identifies antigen-specific peripheral T follicular helper cells in COVID-19 infected patients

Combining genetic and experimental data can enable more accurate prediction of influenza virus

Understanding COVID-19 immunity is crucial for developing vaccination strategies

"Pandemic politics" is causing assaults on science and the public health

A "five-day switch" plan for schools reopenings during COVID-19

Researchers create multi-functional nano-vaccine to prevent toxoplasmosis

AncestryDNA modeling study of 500,000 Americans sheds light on COVID-19 risk factors

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in